Larry P. Bleier, DMD

Larry Bleier, DMD, is a seasoned clinical researcher and periodontist with over 45 years of experience in biomedical research and dental medicine. As the President and CEO of Cutting Edge Technology (CET), he leads the development and manufacturing of innovative sharpening and finishing products designed to improve the safety and effectiveness of periodontal and surgical treatments. Larry’s extensive expertise in periodontics and pharmaceutical care drives his commitment to creating advanced biomedical solutions tailored to the needs of healthcare providers and patients worldwide.

A Harvard School of Dental Medicine alumnus and Clinical Fellow in Periodontology, Larry holds multiple patents related to minimally invasive periodontal therapies, shaping apparatuses, and pharmaceutical formulations that enhance oral and medical treatments. His patented technologies, adopted by dental companies and medical specialists, reflect a deep dedication to improving surgical performance and patient outcomes through biomaterials, controlled surface finishing, and therapeutic agents.

Larry’s work bridges clinical practice, research, and product innovation, with a focus on advancing global healthcare standards. Through Cutting Edge Technology LLC, he offers patented and patent-pending technologies across medical, dental, veterinary, and other industries, supporting licensing and partnership opportunities to expand the impact of his inventions. His commitment to open innovation and biomedical engineering continues to push the boundaries of what is possible in medical device and pharmaceutical development.

• Harvard School of Dental Medicine
• Veterans Administration Hospitals, West Roxbury and Boston, Masschusetts
• University of Pennsylvania
• Rutgers University

• Diplomate American Board of Periodontology

• Northeastern Society of Periodontists
• American Academy of Periodontology
• Internation Academy of Osseointegration